Commemorative Series No. 2 · The Drug Money
OUTSPENTNo. 25/54
Olympia
Snowe
U.S. Senate · R-ME
Taken from pharma & insurers
$34,750
H.R.1 · Medicare drug-price ban · 2003tap to flip ⤺
WHO THEY WORK FORNo. 25/54
Insurers & HMOs$24,750
Pharma & Health$10,000
Banned Medicare from negotiating drug prices for 19 years. Once it could (2024), prices fell 38–79%. · 108-1-459OUTSPENT
Card 25 of 54 · tap the card to see who they work for
Beyond the check
The check is only the part you can see.
They took
$34,750
The industry spent on the bill
$116M
on drug-industry lobbying in 2003, about ten lobbyists for every senator
Then, after office
Took board seats at a Wall Street firm (T. Rowe Price), a health insurer (Aetna), and a consumer lender (Synchrony).
Source: SEC filings, 2013-2014
The industry figure is lobbying spent on the bill, not a payment to this senator. Source: Public Citizen (2004); Center for Public Integrity. Everything here is documented public record; nothing alleges an illegal act.
Don't recognize a logo? Here's the key.
Insurers & HMOs$24,750
Aetna$19,050
Cigna$3,250
AHIP$1,000
Anthem/Elevance$950
Humana$500
Pharma & Health$10,000
Johnson & Johnson$6,500
Amgen$3,000
Merck$500